Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Expert Review of Hematology|December 17, 2016
How ruxolitinib modified the outcome in myelofibrosis: focus on overall survival, allele burden reduction and fibrosis changesFulvio Massaro, Matteo Molica, Massimo Breccia
Current Cancer Drug Targets|October 4, 2017
Ponatinib: A Review of Efficacy and SafetyFulvio Massaro, Matteo Molica, Massimo Breccia
Expert Opinion on Pharmacotherapy|December 1, 2016
Second line small molecule therapy options for treating chronic myeloid leukemiaMatteo Molica, Fulvio Massaro, Massimo Breccia
International Journal of Hematologic Oncology|October 11, 2018
Current first- and second-line treatment options in acute promyelocytic leukemiaFulvio Massaro, Matteo Molica, Massimo Breccia
Expert Review of Molecular Diagnostics|September 21, 2017
Diagnostic and prognostic cytogenetics of chronic myeloid leukaemia: an updateMatteo Molica, Fulvio Massaro, Massimo Breccia
Cancers|November 25, 2023
Supportive Care in Older Lymphoma Patients to Reduce Toxicity and Preserve Quality of LifeFulvio Massaro, Fabio Andreozzi, Charlotte Vandevoorde, et al.
Cureus|May 25, 2026
Acute Upper Limb Ischemia as a Presentation of Arterial Thoracic Outlet Syndrome in a Young Patient: A Case ReportArianna Grilli, Auréline Cousinne, Fulvio Massaro, et al.
Expert Opinion on Pharmacotherapy|May 28, 2016
How has treatment changed for blast phase chronic myeloid leukemia patients in the tyrosine kinase inhibitor era? A review of efficacy and safetySalvatore Perrone, Fulvio Massaro, Giuliana Alimena, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|June 5, 2019
Clinical diagnosis-part I: what is really caused by Chiari IPalma Ciaramitaro, Marilena Ferraris, Fulvio Massaro, et al.
Pageof 4